MAIORANA, Antonino
 Distribuzione geografica
Continente #
NA - Nord America 33.316
EU - Europa 21.140
AS - Asia 14.166
SA - Sud America 2.230
AF - Africa 385
OC - Oceania 60
Continente sconosciuto - Info sul continente non disponibili 29
Totale 71.326
Nazione #
US - Stati Uniti d'America 32.681
IT - Italia 9.137
GB - Regno Unito 4.526
SG - Singapore 4.450
CN - Cina 3.670
BR - Brasile 1.685
HK - Hong Kong 1.633
VN - Vietnam 1.520
SE - Svezia 1.472
DE - Germania 1.415
FI - Finlandia 744
UA - Ucraina 720
RU - Federazione Russa 706
FR - Francia 690
TR - Turchia 608
IN - India 447
IE - Irlanda 401
CA - Canada 363
KR - Corea 353
BG - Bulgaria 281
NL - Olanda 272
BD - Bangladesh 251
ID - Indonesia 230
MX - Messico 174
AR - Argentina 164
JP - Giappone 152
PL - Polonia 129
IQ - Iraq 123
CH - Svizzera 98
PK - Pakistan 97
ZA - Sudafrica 93
AE - Emirati Arabi Uniti 90
MY - Malesia 87
BE - Belgio 81
EC - Ecuador 77
CO - Colombia 76
ES - Italia 72
EG - Egitto 68
CL - Cile 64
PH - Filippine 58
IR - Iran 57
AU - Australia 55
LT - Lituania 55
AT - Austria 52
VE - Venezuela 48
SA - Arabia Saudita 42
UZ - Uzbekistan 39
MA - Marocco 38
PY - Paraguay 37
CZ - Repubblica Ceca 35
TN - Tunisia 34
NG - Nigeria 33
DZ - Algeria 32
PE - Perù 32
RO - Romania 32
AL - Albania 30
KE - Kenya 30
IL - Israele 27
JO - Giordania 27
PT - Portogallo 26
RS - Serbia 26
AZ - Azerbaigian 24
TH - Thailandia 24
TW - Taiwan 24
GR - Grecia 23
UY - Uruguay 22
BO - Bolivia 21
EU - Europa 19
DK - Danimarca 17
KZ - Kazakistan 17
NP - Nepal 17
CR - Costa Rica 16
OM - Oman 15
BY - Bielorussia 14
DO - Repubblica Dominicana 14
ET - Etiopia 14
HR - Croazia 14
PA - Panama 12
BH - Bahrain 11
HU - Ungheria 11
SK - Slovacchia (Repubblica Slovacca) 10
GE - Georgia 9
PS - Palestinian Territory 9
BZ - Belize 8
LB - Libano 8
MD - Moldavia 8
GT - Guatemala 7
HN - Honduras 7
JM - Giamaica 7
KG - Kirghizistan 7
LK - Sri Lanka 7
MK - Macedonia 7
PR - Porto Rico 7
BB - Barbados 6
EE - Estonia 6
LU - Lussemburgo 6
SI - Slovenia 6
AM - Armenia 5
CY - Cipro 5
NO - Norvegia 5
Totale 71.214
Città #
Southend 3.141
Ashburn 3.057
Fairfield 2.981
Santa Clara 2.914
Singapore 2.905
Chandler 1.801
Woodbridge 1.606
Hong Kong 1.587
Houston 1.409
Jacksonville 1.260
Seattle 1.130
San Jose 1.093
Dearborn 1.086
Wilmington 1.041
Ann Arbor 1.025
Cambridge 1.006
Hefei 995
Nyköping 878
Milan 766
Chicago 758
Beijing 720
Los Angeles 678
London 677
New York 579
Rome 554
Helsinki 486
Ho Chi Minh City 465
Modena 443
Dublin 386
The Dalles 381
Council Bluffs 365
Hanoi 338
Izmir 334
Salt Lake City 334
San Diego 323
Seoul 318
Munich 299
Princeton 293
Sofia 265
Lauterbourg 221
Eugene 210
Dallas 202
Bologna 195
Moscow 191
Buffalo 188
Shanghai 183
Naples 171
São Paulo 164
Tampa 152
Florence 150
Jakarta 144
Elk Grove Village 140
Frankfurt am Main 118
Orem 100
Redwood City 98
Tokyo 94
Toronto 92
Palermo 85
Bremen 83
Fremont 81
Da Nang 79
Des Moines 79
Phoenix 79
Bari 78
Warsaw 78
Sterling 77
Turin 77
Lancaster 71
Haiphong 70
Boardman 68
Columbus 68
Ottawa 65
Mumbai 63
Padova 63
Turku 62
Brussels 58
New Delhi 58
Chennai 57
Grafing 54
Mexico City 54
Atlanta 53
Brooklyn 52
Guangzhou 52
Norwalk 51
Cagliari 50
Falls Church 50
Genoa 50
Catania 49
Dong Ket 49
Parma 48
Denver 47
Rio de Janeiro 46
Miami 45
Stockholm 45
Baghdad 44
Johannesburg 43
Napoli 43
Nuremberg 42
Kunming 41
Amsterdam 40
Totale 46.037
Nome #
Angiomixoma aggressivo della pelvi e del perineo. Presentazione di un caso clinico e revisione della letteratura 6.156
VALORE PROGNOSTICO E PREDITTIVO DI p53 NEL CARCINOMA MAMMARIO TRATTATO CON CHEMIOTERAPIA NEOADIUVANTE 1.144
Type 3 hypersensitivity in COVID-19 vasculitis 984
Spiradenoma eccrino al dorso della mano: presentazione di un caso 641
Post-mortem diagnosis of encephalitis in a 75-year-old man associated with human herpesvirus-6 variant A 586
COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion 505
Ex-vivo Fluorescence Confocal Microscopy: The First Application For Real-Time Pathologic Examination of Prostatic Tissue 477
Incidence, clinical characteristics and survival of malignant lymphomas: a population-based study from a cancer registry in northern Italy. 467
Impressive response to dose-dense chemotherapy in a patient with NUT midline carcinoma 466
Liver Angiopoietin-2 is a key predictor of de novo or recurrent hepatocellular cancer after HCV direct-acting antivirals 444
Microenvironment inflammatory infiltrate drives growth speed and outcome of hepatocellular carcinoma: a prospective clinical study 433
Atypical Spitzoid melanocytic tumors:A morphological, mutational, and FISH analysis 423
Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management 420
Cutaneous metastases as the first manifestation of pleural malignant mesothelioma. 418
Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer 417
Assessment of freezing effects and diagnostic potential of BioBank healthy and neoplastic breast tissues through HR-MAS NMR spectroscopy 416
Alterations of 9p21 analysed by FISH and MLPA distinguish atypical spitzoid melanocytic tumours from conventional Spitz's nevi but do not predict their biological behaviour 415
The miR-196b miRNA inhibits the GATA6 intestinal transcription factor and is upregulated in colon cancer patients 409
A case of primary cardiac angiosarcoma: extensive right atrial wall reconstruction with autologous pericardium. 407
Cytomegalovirus infection of the upper gastrointestinal tract: a clinical and pathological study of 30 cases. 397
Well-differentiated papillary mesothelioma of the epididymis in a man with recurrent haematospermia. 392
Granular cell tumor of the appendix: a new case and review of the literature 387
Superficial papillary urothelial carcinomas in young and elderly patients: a comparative study. 385
Sentinel lymph node biopsy in clear cell sarcoma. 383
Localized pleural metastatic adenosarcoma of the uterine cervix mimicking a malignant solitary fibrous tumour: CD10 has no value in differential diagnosis 378
Differential molecular pathways expression in HER2 positive early breast cancer according to hormone receptor status. 377
INI1 immunohistochemical expression in glioblastoma: correlation with MGMT gene promoter methylation status and patient survival 376
SOLUBLE TRAIL-ARMED HUMAN AD-MSC AS NOVEL CELL THERAPY APPROACH FOR PANCREATIC DUCTAL ADENOCARCINOMA 374
Phase II, randomized trial of preoperative epirubicin-paclitaxel +/- gefitinib with biomarker evaluation in operable breast cancer. 374
Experimental varicocele in the rat: early evaluation of the nitric oxide levels and histological alterations in the testicular tissue. 370
MODULAZIONE DELL’ESPRESSIONE DI BIOMARCATORI E PROGNOSI IN PAZIENTI AFFETTE DA CARCINOMA MAMMARIO OPERABILE SOTTOPOSTE A CHEMIOTERAPIA PREOPERATORIA 368
A prognostic model based on nodal status and Ki-67 predicts the risk of recurrence and death in breast cancer patients with residual disease after preoperative chemotherapy 368
Bone marrow failure associated with human herpesvirus 8 infection after transplantation 364
Placental transmogrification of the lung: Clinicopathologic, immunohistochemical and molecular study of two cases, with particular emphasis on the interstitial clear cells 362
Genomic alterations at the basis of treatment resistance in metastatic breast cancer: Clinical applications 360
Acquired immunodeficiency similar to Gulf War illness in a dead former serviceman 356
Human herpesvirus-8 DNA sequences in Human Immunodeficiency Virus-negative angioimmunoblastic lymphadenopathy and benign lymphadenopathy with giant germinal center hyperplasia and increased vascularity 353
Mutational Profile of Metastatic Breast Cancer Tissue in Patients Treated with Exemestane Plus Everolimus 353
Malacoplachia del testicolo. Descrizione di un caso. 351
Dystroglycan expression is reduced during prostate tumorigenesis and is regulated by androgens in prostate cancer cells 351
Human cytomegalovirus infection of the gastrointestinal tract in apparently immunocompetent patients 347
Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer. 344
Prognostic significance of MGMT gene promoter methylation in differently treated metastatic melanomas 341
"Is this case of a very rare disease work-related?" a review of reported cases of pacinian neuroma 338
Ex vivo fluorescence confocal microscopy: prostatic and periprostatic tissues atlas and evaluation of the learning curve 338
Epidermal growth factor receptor gene copy number, K-ras mutation and pathological response to preoperative cetuximab, 5-FU and radiation therapy in locally advanced rectal cancer.. 337
Role of chemotherapy and the receptor tyrosine kinases KIT, PDGFR alpha, PDGFR beta, and met in large-cell neuroendocrine carcinoma of the lung 337
Correlating tumor-infiltrating lymphocytes and lung cancer stem cells: a cross-sectional study. 336
Molecular Profile, as detected with Mass-Array Spectrometry (Sequenom platform), in primary and metastatic breast carcinoma treated with Exemestane + Everolimus 335
Psoriasis vs allergic contact dermatitis in palms and soles: A quantitative histologic and immunohistochemical study 334
Prognostic relevance of serum beta2 microglobulin in patients with follicular lymphoma treated with anthracycline-containing regimens. A GISL study. 333
Survivin modulates squamous cell carcinoma-derived stem-like cell proliferation, viability and tumor formation in vivo 332
Surgical margins in head and neck squamous cell carcinoma: what is 'close'? 329
Predictive and prognostic role of p53 according to tumor phenotype in breast cancer patients treated with preoperative chemotherapy: a single-institution analysis 326
ALDH Expression in Angiosarcoma of the Lung: A Potential Marker of Aggressiveness? 324
NF1 truncating mutations associated to aggressive clinical phenotype with elephantiasis neuromatosa and solid malignancies 320
Role of evaluating tumor‑infiltrating lymphocytes, programmed death‑1 ligand 1 and mismatch repair proteins expression in malignant mesothelioma 320
Clinical and molecular predictors of long-term response in HER2 positive metastatic breast cancer patients. 319
BRAFp.V600E, p.V600K, and p.V600R Mutations in Malignant Melanoma: Do They Also Differ in Immunohistochemical Assessment and Clinical Features? 317
Prediction of distant recurrence in resected stage I and II lung adenocarcinoma 316
BRAF V600E mutation in washing liquid of thyroid fine-needle aspiration: a surprising tool in cytological benign nodules. 313
Analysis of KRAS, NRAS, PIK3CA, and BRAF mutational profile in poorly differentiated clusters of KRAS-mutated colon cancer 310
Modulation of Mutational Landscape in HER2-Positive Breast Cancer after Neoadjuvant Chemotherapy 310
Differential gene expression patterns in HER2 positive metastatic breast cancer patients according to hormone receptor status 309
Isolation and Characterization of Squamous Cell Carcinoma-Derived Stem-like Cells: Role in Tumor Formation 308
Overall survival in patients with lung adenocarcinoma harboring "niche" mutations: an observational study 308
Real-time assessment of surgical margins during radical prostatectomy: a novel approach that uses fluorescence confocal microscopy for the evaluation of peri-prostatic soft tissue 303
Molecular profile in primary and metastatic breast cancer treated with Exemestane and Everolimus. 300
A randomized controlled trial comparing three single-incision minislings for stress urinary incontinence 299
Dismal outcome of t-cell lymphoma patients failing first-line treatment: results of a population-based study from the Modena Cancer Registry 298
Durable remission in a patient with leptomeningeal relapse of a MYC/BCL6-positive double-hit DLBCL treated with lenalidomide monotherapy 298
Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation 296
Cancer Stem-Like Cells in a Case of an Inflammatory Myofibroblastic Tumor of the Lung. 296
Cancer stem-neuroendocrine cells in an atypical carcinoid case report. 295
Adenolipoma della trachea. Descrizione di un caso trattato mediante resezione-anastomosi tracheale. 294
Decreasing incidence of gastric MALT lymphomas in the era of anti-Helicobacter pilori interventions: results from a population-based study on extranodal marginal zone lymphomas 287
ASSESSMENT OF FREEZING EFFECTS AND DIAGNOSTIC POTENTIAL OF BIOBANK HEALTHY AND NEOPLASTIC BREAST TISSUES THROUGH HR-MAS NMR SPECTROSCOPY 286
An unusual case of signet ring cell adenocarcinoma of the prostate 286
Can prostatitis to be a confounding parameter in prostatic proteomic profile designation? 284
Does HPV play a role in the etiopathogenesis of ameloblastoma? An immunohistochemical, in situ hybridization and polymerase chain reaction study of 18 cases using laser capture microdissection 283
Pre-miR146a expression in follicular carcinomas of the thyroid 282
Expression of nuclear survivin in normal skin and squamous cell carcinoma: a possible role in tumor invasion 281
Identification of families with hereditary breast and ovarian cancer for clinical and mammographic surveillance: the Modena Study Group proposal 280
CD44+/EPCAM+ cells detect a subpopulation of ALDHhigh cells in human non-small cell lung cancer: A chance for targeting cancer stem cells? 279
Pre-miR146a expression profiling of follicular thyroid carcinoma 278
Isolation and Identification of Cancer Stem-Like Cells in Adenocarcinoma and Squamous Cell Carcinoma of the Lung: A Pilot Study 278
Double-blind, placebo-controlled, multicenter, randomized, phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative, operable breast cancer 276
p16 immunohistochemistry of multiple primary melanomas as screening to identify Familial Melanoma Syndrome 273
Gastrointestinal stromal tumor and other primary metachronous and synchronous neoplasms as a suspicious criterion for syndromic setting 271
Mutations and somatic changes in the genotype of rs2910164 in pre-miR146a are frequent in follicular thyroid carcinoma 269
A new case of juxtaglomerular cell tumor in a patient with bilateral adrenalectomy because of MEN2A 269
Prospective biomarker analysis of the randomized CHER-LOB study evaluating the dual anti-HER2 treatment with trastuzumab and lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive breast cancer 269
Heavy Metal Bioaccumulation in an Atypical Primitive Neuroectodermal Tumor of the Abdominal Wall. 268
CLINICAL AND PATHOLOGICAL FEATURES OF BREAST CANCER IN PATIENTS WITH SYSTEMIC SCLEROSIS: PRELIMINARY DATA FROM THE SCLERO-BREAST STUDY 263
Differential gene expression patterns in HER2 positive metastatic breast cancer patients according to hormone receptor status. 262
Expression and clinicopathological role of miR146a in thyroid follicular carcinoma. 262
Expression of ALDH and SOX-2 in Pulmonary Sclerosing Pnemocytoma (PSP) of the Lung: Is There a Meaning Behind? 261
A proof of evidence supporting abnormal immunothrombosis in severe COVID-19: naked megakaryocyte nuclei increase in the bone marrow and lungs of critically ill patients 259
Expression of p27(kip1) in basal cell carcinomas and trichoepitheliomas 258
Rhabdomyoma of a rare type in a child: Case report and literature review 254
Totale 41.385
Categoria #
all - tutte 252.532
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 252.532


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.003 0 0 0 0 0 0 0 0 0 0 610 393
2021/20226.213 410 665 483 500 223 405 289 333 645 541 1.019 700
2022/20236.327 711 638 454 564 647 758 227 519 997 135 322 355
2023/20244.857 198 275 241 450 951 515 435 492 141 281 381 497
2024/202511.736 471 206 278 866 2.169 1.764 941 737 1.296 643 989 1.376
2025/202620.494 1.306 794 1.721 2.999 4.368 1.385 2.221 1.037 1.990 1.729 944 0
Totale 71.877